NCT04367506 is a NA clinical trial of BecomeAnEX in Tobacco Cessation, sponsored by University of Maryland, Baltimore.

Who is sponsoring NCT04367506?

NCT04367506 is sponsored by University of Maryland, Baltimore.

What drugs are being tested in NCT04367506?

Interventions in NCT04367506: BecomeAnEX, Usual Care.

What condition does NCT04367506 study?

NCT04367506 studies Tobacco Cessation.

Is NCT04367506 still recruiting?

NCT04367506 is currently completed. Last updated 23 January 2025.

Last reviewed 2025-01-23 · How we verify

NCT04367506

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

Completed NA Last updated 23 January 2025

What this trial tests

NA trial testing BecomeAnEX in Tobacco Cessation in 59 participants. Completed in 18 December 2024.

Timeline

1 January 2021

Primary endpoint
31 July 2024

18 December 2024

Quick facts

Lead sponsor	University of Maryland, Baltimore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	59
Start date	1 January 2021
Primary completion	31 July 2024
Estimated completion	18 December 2024
Sites	2 locations across United States

Drugs / interventions tested

BecomeAnEX
Usual Care

Conditions studied

Tobacco Cessation — all drugs for Tobacco Cessation →

Sponsor

University of Maryland, Baltimore

Who can join

18 and older, any sex, with Tobacco Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to adapt a digital intervention both to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting through a collaboration between experts in SMI and the Truth Initiative, a pre-eminent tobacco control organization. The investigators believe this will bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population.
Petkovic J, Duench S, Trawin J, Dewidar O, et al · · 2021 · cited 78× · PMID 34057201 · DOI 10.1002/14651858.cd012932.pub2
Bridging the Hospital Discharge Gap: Pilot Trial of a Digital Smoking Cessation Program for Psychiatric Inpatients.
Bennett ME, Dickerson F, Cha S, Brandler BJ, et al · · 2026 · PMID 41881842 · DOI 10.1176/appi.ps.20250326

Verify or expand the search:

Other recruiting trials for Tobacco Cessation

Currently open trials in the same condition.

NCT07098065 — Health Warnings and Counseling for Smoking Cessation · NA · recruiting
NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
NCT05429892 — FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers · NA · recruiting
NCT04865276 — Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHe · NA · recruiting

Other University of Maryland, Baltimore trials

Trials by the same sponsor.

NCT07537413 — Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia · Phase 4 · not yet recruiting
NCT07221799 — OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis · Phase 1 · not yet recruiting
NCT07094672 — Development of an Opioid Withdrawal Clinical Outcome Assessment · not yet recruiting
NCT06583239 — Hub-Based Engagement Navigator Service to Reduce CSC Disengagement · NA · not yet recruiting
NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04367506 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Maryland, Baltimore
Last refreshed: 23 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04367506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing